3
Participants
Start Date
May 3, 2019
Primary Completion Date
February 15, 2022
Study Completion Date
February 15, 2022
Pentosan Polysulfate Na 100Mg Cap
"Participants will be randomly assigned to receive Pentosan Polysulfate Na 100Mg Cap TID for 6 weeks.~For blinded distribution, each bottle of medications will be labeled with a random number for identification.~The study participants will be monitored every 2 weeks with phone calls from the study team to evaluate their condition and decide if the medication is tolerated and whether it should be continued or stopped."
Placebo oral capsule
"Participants will be randomly assigned to receive Placebo oral capsule TID for 6 weeks.~For blinded distribution, each bottle of medications will be labeled with a random number for identification.~The study participants will be monitored every 2 weeks with phone calls from the study team to evaluate their condition and decide if the medication is tolerated and whether it should be continued or stopped."
Jewish General Hospital, Montreal
Collaborators (1)
Cancer Research Network
OTHER
Sir Mortimer B. Davis - Jewish General Hospital
OTHER